Functional analyses of liver cell populations from mice harboring CRC liver metastases treated systemically with albumin-CuET nanoparticles revealed enhanced NK and NKT cell cytotoxicity against CRC cells, partially explaining the antimetastatic activity of the drug (Figure 3). Here, ALB is linked to colorectal carcinoma.